Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study
NCT ID: NCT00552136
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
250 participants
INTERVENTIONAL
2005-05-30
2030-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study of Total Ankle Arthroplasty and Tibiotalar Arthrodesis
NCT02025946
Gait Analysis of Ankle Arthroplasty and Arthrodesis
NCT00921076
Total Ankle Replacement: Clinical and Radiological Outcomes
NCT03650010
Total Ankle Replacement for Ankle Arthritis
NCT01986244
Treatment of Post Traumatic Asymmetrical Ankle Arthritis Using Low Tibial Osteotomy
NCT04100746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ankle Arthroplasty
Ankle Arthroplasty
Ankle Artrodeses
Ankle Arthrodesis
Ankle fusion surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ankle Arthroplasty
Ankle Arthrodesis
Ankle fusion surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Known to have ankle arthritis for more than six (6) months
* Tried non operative treatment measures (eg. activity modification, physiotherapy, orthotics, bracing etc.) and have not improved
* Patient tests (questionnaires) show that ankle arthritis is severe
* Patient willing to take part in the study, including signing consent form after carefully reading it
Exclusion Criteria
* Severe foot or Ankle Deformity
* Prior Ankle Fusion or Replacement
* Active or Prior Infection in the Ankle
* Obesity (greater than 250 lbs)
* Medical Conditions precluding safe surgery
* Nerve or Muscle disease
* Severe osteoporosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Orthopaedic Foot and Ankle Society
OTHER
Johnson & Johnson
INDUSTRY
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Glazebrook, MD
Role: PRINCIPAL_INVESTIGATOR
Capital District Health Authority, Halifax Canada
Tim Daniels, MD
Role: PRINCIPAL_INVESTIGATOR
St. Michael's Hospital (Toronto, Canada)
Alistair Younger, MD
Role: PRINCIPAL_INVESTIGATOR
British Columbia Canada
Johnny Lau, MD
Role: PRINCIPAL_INVESTIGATOR
TorontoWestern Hospital, Toronto Canada
Peter Dryden, MD
Role: PRINCIPAL_INVESTIGATOR
Victoria, British Columbia Canada
Murry Penner, MD
Role: PRINCIPAL_INVESTIGATOR
British Columbia,Canada
Kevin Wing, MD
Role: PRINCIPAL_INVESTIGATOR
British Columbia, Canada
Craig Stone, MD
Role: PRINCIPAL_INVESTIGATOR
Newfoundland, Canada
Dave Stevens, MD
Role: PRINCIPAL_INVESTIGATOR
Waterloo, Ontario Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDHA-MG-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.